| Copper deficiency anemia ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed Annals of hematology 97, 1527-1534, 2018 | 259 | 2018 |
| Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses AM Al-Ghananeem, H Saeed, R Florence, RA Yokel, AH Malkawi Journal of drug targeting 18 (5), 381-388, 2010 | 135 | 2010 |
| NCCN guidelines® insights: B-cell lymphomas, version 5.2021: featured updates to the NCCN guidelines AD Zelenetz, LI Gordon, JE Chang, B Christian, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 19 (11), 1218-1230, 2021 | 110 | 2021 |
| Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ... Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022 | 62 | 2022 |
| Pembrolizumab associated hemophagocytic lymphohistiocytosis D Shah, R Shrestha, R Ramlal, J Hatton, H Saeed Annals of Oncology 28 (6), 1403, 2017 | 48 | 2017 |
| Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting H Saeed, RR Woods, J Lester, R Herzig, Z Gul, G Monohan International journal of hematology 102, 195-199, 2015 | 42 | 2015 |
| Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer AT Le, B Huang, D Hnoosh, H Saeed, SP Dineen, PJ Hosein, EB Durbin, ... Journal of Surgical Research 214, 1-8, 2017 | 19 | 2017 |
| Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis H Saeed, D Hnoosh, B Huang, EB Durbin, PC McGrath, P Desimone, ... Journal of surgical oncology 114 (4), 451-455, 2016 | 18 | 2016 |
| CNS prophylaxis during front-line therapy in aggressive non-Hodgkin lymphomas: real-world outcomes and practice patterns from 19 US academic institutions VM Orellana-Noia, DR Reed, JM Sen, C Barlow, MK Malecek, BS Kahl, ... Blood 136, 27-28, 2020 | 16 | 2020 |
| Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies N Shah, MA Perales, CJ Turtle, MS Cairo, AJ Cowan, H Saeed, LE Budde, ... Future Oncology 17 (27), 3549-3560, 2021 | 15 | 2021 |
| A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation L Chen, E Romond, S Chokshi, H Saeed, J Hodskins, M Stevens, ... Breast cancer research and treatment 136, 565-572, 2012 | 14 | 2012 |
| Nivolumab (N)‐AVD improves progression‐free survival compared to brentuximab vedotin (BV)‐AVD in advanced stage (AS) classic Hodgkin lymphoma (hl): results of SWOG S1826 AF Herrera, M LeBlanc, SM Castellino, H Li, SC Rutherford, AM Evens, ... Hematological Oncology 41, 33-35, 2023 | 11 | 2023 |
| Multimodality therapy improves survival in intramedullary spinal cord metastasis of lung primary H Saeed, R Patel, J Thakkar, L Hamoodi, L Chen, JL Villano Hematology/oncology and stem cell therapy 10 (3), 143-150, 2017 | 11 | 2017 |
| NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023: Featured Updates to the NCCN Guidelines AD Zelenetz, LI Gordon, JS Abramson, RH Advani, B Andreadis, ... Journal of the National Comprehensive Cancer Network 21 (11), 1118-1131, 2023 | 10 | 2023 |
| Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry ZW Myint, R Shrestha, S Siddiqui, S Slone, B Huang, R Ramlal, ... Hematology/Oncology and Stem Cell Therapy 13 (1), 17-22, 2020 | 8 | 2020 |
| Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement H Saeed, M Awasthi, A Al-Qaisi, S Massarweh Rare Tumors 6 (4), 121-123, 2014 | 8 | 2014 |
| Outcomes of patients with limited‐stage plasmablastic lymphoma: a multi‐institutional retrospective study BT Hess, A Giri, Y Park, KK Patel, BK Link, GS Nowakowski, SM Maliske, ... American journal of hematology 98 (2), 300-308, 2023 | 7 | 2023 |
| Hypertrophic Pulmonary Osteoarthropathy and Tripe Palms H Saeed, S Massarweh New England Journal of Medicine 366 (4), 360-360, 2012 | 7 | 2012 |
| Classical Hodgkin lymphoma: clinicopathologic features, prognostic factors, and outcomes from a 28-Year single institutional experience A Rose, A Grajales-Cruz, A Lim, A Todd, C Bello, B Shah, J Chavez, ... Clinical Lymphoma Myeloma and Leukemia 21 (2), 132-138, 2021 | 5 | 2021 |
| Use of lenalidomide plus rituximab in TP53-mutated mantle cell lymphoma (MCL) outside of clinic trial: the moffitt experience N Shah, F Castillo-Tokumori, JC Chavez, L Isenalumhe, H Saeed, C Bello, ... Blood 134, 3991, 2019 | 5 | 2019 |
